AW
TMO icon

Alaethes Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Alaethes Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,955
Closed -$1.47M – 114
2025
Q1 		$1.47M Buy
2,955
+134
+5% +$72.6K 0.54% 72
2024
Q4 		$1.47M Sell
2,821
-23
-0.8% -$12.6K 0.52% 68
2024
Q3 		$1.76M Sell
2,844
-249
-8% -$147K 0.65% 54
2024
Q2 		$1.71M Buy
3,093
+90
+3% +$51.6K 0.71% 48
2024
Q1 		$1.75M Buy
3,003
+65
+2% +$36.5K 0.76% 52
2023
Q4 		$1.56M Buy
2,938
+118
+4% +$57.1K 0.74% 49
2023
Q3 		$1.43M Buy
2,820
+208
+8% +$111K 0.78% 45
2023
Q2 		$1.36M Buy
2,612
+78
+3% +$42.1K 0.75% 51
2023
Q1 		$1.46M Buy
2,534
+70
+3% +$39.5K 0.86% 40
2022
Q4 		$1.36M Buy
2,464
+78
+3% +$41.3K 0.93% 42
2022
Q3 		$1.21M Buy
2,386
+100
+4% +$56K 0.89% 35
2022
Q2 		$1.24M Buy
2,286
+108
+5% +$59.4K 0.92% 34
2022
Q1 		$1.29M Sell
2,178
-195
-8% -$112K 0.82% 44
2021
Q4 		$1.58M Buy
2,373
+180
+8% +$112K 1% 28
2021
Q3 		$1.25M Buy
2,193
+94
+4% +$51.6K 0.91% 38
2021
Q2 		$1.06M Buy
2,099
+411
+24% +$194K 0.82% 46
2021
Q1 		$770K Buy
+1,688
New +$806K 0.71% 58

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Alaethes Wealth's TMO Position: Q2 2025 in Review

Alaethes Wealth sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 2,955 shares — an estimated $1.47M sold.

Alaethes Wealth first reported a position in TMO in Q1 2021 and held it in 17 quarters. The position peaked at $1.76M in Q3 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Alaethes Wealth reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Alaethes Wealth sold 2,955 Thermo Fisher Scientific shares in Q2 2025, an estimated $1.47M.
  • Alaethes Wealth first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 17 quarters.
  • Alaethes Wealth's Thermo Fisher Scientific position peaked at $1.76M in Q3 2024.
  • 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Alaethes Wealth's 13F filing for Q2 2025, filed 15 Aug 2025.